Vad Vijay B, Bhat Atul L, Lutz Gregory E, Cammisa Frank
The Hospital for Special Surgery, New York, New York 10021, USA.
Spine (Phila Pa 1976). 2002 Jan 1;27(1):11-6. doi: 10.1097/00007632-200201010-00005.
A prospective study randomized by patient choice from the private practice of a single physician affiliated with a major teaching hospital was conducted.
To compare transforaminal epidural steroid injections with saline trigger-point injections used in the treatment of lumbosacral radiculopathy secondary to a herniated nucleus pulposus.
Epidural steroid injections have been used for more than half a century in the management of lumbosacral radicular pain. At this writing, however, there have been no controlled prospective trials of transforaminal epidural steroid injections in the treatment of lumbar radiculopathy secondary to a herniated nucleus pulposus.
Randomized by patient choice, patients received either a transforaminal epidural steroid injection or a saline trigger-point injection. Treatment outcome was measured using a patient satisfaction scale with choice options of 0 (poor), 1 (fair), 2 (good), 3 (very good), and 4 (excellent); a Roland-Morris low back pain questionnaire that showed improvement by an increase in score; a measurement of finger-to-floor distance with the patient in fully tolerated hip flexion; and a visual numeric pain scale ranging from 0 to 10. A successful outcome required a patient satisfaction score of 2 (good) or 3 (very good), improvement on the Roland-Morris score of 5 or more, and pain reduction greater than 50% at least 1 year after treatment. The final analysis included 48 patients with an average follow-up period of 16 months (range, 12-21 months).
After an average follow-up period of 1.4 years, the group receiving transforaminal epidural steroid injections had a success rate of 84%, as compared with 48% for the group receiving trigger-point injections (P < 0.005).
Fluoroscopically guided transforaminal injections serve as an important tool in the nonsurgical management of lumbosacral radiculopathy secondary to a herniated nucleus pulposus.
开展了一项前瞻性研究,该研究通过患者自主选择,从一家与大型教学医院相关联的单一医生私人诊所中进行随机分组。
比较经椎间孔硬膜外类固醇注射与生理盐水触发点注射在治疗因髓核突出导致的腰骶神经根病中的效果。
硬膜外类固醇注射已用于腰骶部神经根性疼痛的治疗超过半个世纪。然而,在撰写本文时,尚无关于经椎间孔硬膜外类固醇注射治疗因髓核突出导致的腰椎神经根病的对照前瞻性试验。
通过患者自主选择进行随机分组,患者接受经椎间孔硬膜外类固醇注射或生理盐水触发点注射。使用患者满意度量表进行测量,量表的选择选项为0(差)、1(一般)、2(好)、3(非常好)和4(优秀);使用罗兰 - 莫里斯下背痛问卷,通过分数增加来显示改善情况;测量患者在完全耐受的髋关节屈曲状态下手指到地面的距离;以及使用从0到10的视觉数字疼痛量表。成功的结果要求患者满意度评分为2(好)或3(非常好),罗兰 - 莫里斯评分提高5分或更多,并且在治疗后至少1年疼痛减轻超过50%。最终分析纳入了48例患者,平均随访期为16个月(范围为12 - 21个月)。
平均随访1.4年后,接受经椎间孔硬膜外类固醇注射的组成功率为84%;相比之下,接受触发点注射的组成功率为48%(P < 0.005)。
在荧光镜引导下经椎间孔注射是治疗因髓核突出导致的腰骶神经根病非手术治疗中的重要工具。